Form 4 for LUNG Pulmonx Corp
Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001209191-22-048780 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-06 | 2022-09-01 | LUNG | French Glendon E. III | Pres, CEO, Dir | S - Sale | $17.87 | -2,940 | 1.05M | -0.3% | -$52.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-01 | S | D | 1,926 | $17.87 | 1,052,944 | D | — | — | |
| 2 | Common | Common Stock | 2022-09-01 | S | D | 1,014 | $17.87 | 1,054,870 | D | — | — |